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Abstract Directed differentiation of adult multipotent stro-
mal cells (MSC) is critical for effective treatment strategies.
This study was designed to evaluate the capability of equine
MSC from bone marrow (BMSC) and adipose tissue (ASC)
on a type I collagen (COLI) scaffold to undergo chondrogenic,
osteogenic and adipogenic differentiation and form extracel-
lular matrix (ECM) in vitro. Following determination of sur-
face antigen expression, MSC were loaded into scaffolds in a
perfusion bioreactor and loading efficiency was quantified.
Cell-scaffold constructs were assessed after loading and 7, 14
and 21 days of culture in stromal or induction medium. Cell
number was determined with DNA content, cell viability and
spatial uniformity with confocal laser microscopy and cell
phenotype and matrix production with light and scanning
electron microscopy and mRNA levels. The MSC were
positive for CD29 (>90 %), CD44 (>99 %), and CD105
(>60 %). Loading efficiencies were >70 %. The ASC and
BMSC cell numbers on scaffolds were affected by culture
in induction medium differently. Viable cells remained
uniformly distributed in scaffolds for up to 21 days and
could be directed to differentiate or to maintain an MSC
phenotype. Micro- and ultrastructure showed lineage-specific
cell and ECM changes. Lineage-specific mRNA levels dif-
fered between ASC and BMSC with induction and changed
with time. Based on these results, equine ASC and BMSC
differentiate into chondrogenic, osteogenic and adipogenic
lineages and form ECM similarly on COLI scaffolds. The
collected data supports the potential for equine MSC-COLI
constructs to support diverse equine tissue formation for con-
trolled biological studies.
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Introduction
Multipotent stromal cells (MSC) in combination with bio-
compatible scaffolds may augment current therapies to re-
store equine tissue damaged by trauma or disease [1, 2]. In
vitro expansion and mesenchymal lineage differentiation
efficiencies are not identical between adult equine bone
marrow- (BMSC) and adipose (ASC) derived multipotent
stromal cells, two of the best characterized equine MSC
[3–6]. While outcomes vary among species and culture con-
ditions, it is often thought that BMSC have better
chondrogenic and osteogenic capabilities while ASC seem
to have the best adipogenesis [4, 5]. The tissue of origin may
influence the ability of MSC to differentiate along specific
lineages [7]. Hence, cells from different tissues may
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demonstrate varying differentiation capacities under identi-
cal culture conditions.
Biocompatible scaffolds that replicate target tissue micro-
environments effectively support tissue formation by MSC
[8]. Collagen is a major component of ECM, and the cell
interactions with collagen matrix are thought to closely re-
semble those in the native cell-tissue milieu [9]. Scaffolds
composed of collagen are bioabsorbable, have high cell
affinity and support multipotent cell proliferation [10–13].
Collagen based scaffolds in combination with undifferenti-
ated cells support diverse tissue generation including adipose
[13], bone [14], cartilage [15, 16], bladder [17], heart [18]
and skin [19], among others. Type I collagen (COLI) im-
plants are commercially available [20]. Comprehensive
in vitro evaluations of interactions between COLI scaffold
and equine ASC and BMSC, are necessary to establish the
potential of equine MSC-COLI constructs to support diverse
mesenchymal tissue generation. The resulting information is
critical for future generation of custom tissue implants to
augment fracture, wound and intra-articular therapies.
Bioreactors provide controlled environments for cell
loading and significantly contribute to the density and uni-
formity of cell distribution [21–23]. Compared to static
methods of cell loading like droplet and cell suspension,
dynamic cell loading results in higher seeding efficiency
and more even cell distribution [23]. Additionally, cells
seeded by perfusion tend to have more uniform distribution
compared to static and spinner flask methods of cell loading
[22]. High cell loading efficiency reduces the initial cell
numbers required to reach optimum scaffold cell densi-
ties and thus decreases cell expansion time [24], and
uniform cell loading throughout the scaffold contributes
to homogenous tissue generation [25]. Use of a perfu-
sion bioreactor to load adult equine MSC onto biocom-
patible scaffolds may therefore positively impact in vitro
generation of tissue-specific equine MSC-scaffold con-
structs designed to direct tissue formation following
implantation.
A series of related experiments were conducted to
characterize adult equine BMSC and ASC mesenchymal
trilineage differentiation and extracellular matrix produc-
tion on COLI scaffolds. The first hypothesis tested was
that equine BMSC and ASC have indistinguishable cell
loading efficiency, viability, and spatial distribution on
COLI scaffolds under identical perfusion bioreactor load-
ing conditions and subsequent culture. The second hy-
pothesis was that under matching adipogenic, osteogenic,
and chondrogenic culture conditions, BMSC on COLI
scaffolds have higher target tissue messenger ribonucleic
acid (mRNA) levels and support more efficient osteogen-
ic and chondrogenic extracellular matrix (ECM) forma-




Tissue harvest procedures were approved by the Institutional
Animal Care and Use Committee (protocol #11-047).
Stromal cells from four thoroughbred geldings (7–10 years)
were isolated immediately after tissue harvest from sternal
bone marrow and subcutaneous adipose over the gluteal
musculature [4, 5]. Cryopreserved cell passage (P) 1 adult
equine ASC and BMSC were revitalized and expanded to
P3. For purposes of this study, all expansion procedures were
performed in T75 flasks with a seeding density of 5×103
cells/cm2 and cell passage at 75 % confluence. Cells (106
cells/scaffold) were loaded into bovine corium COLI
(AviteneTM UltrafoamTM Collagen Sponge, Davol Inc., sub-
sidiary of C.R. Bard, Inc. Warwick, RI, USA) in perfusion
bioreactors. Loading efficiency was evaluated immediately
after cell seeding. Constructs were cultured in stromal
(basal), adipogenic, osteogenic or chondrogenic medium.
Viability, spatial distribution on COLI scaffolds and construct
microstructure were determined with confocal laser scanning
and light microscopy, respectively, immediately after loading
and 7, 14 and 21 days of culture. Deoxyribonucleic acid
(DNA) and total ribonucleic acid (RNA) were isolated to
quantify cell numbers and target gene mRNA levels at the
same time points. Ultrastructure was assessed with scanning
electron microscopy (SEM) after 21 days. A total of 12 scaf-
folds measuring 10×7×2 mm were prepared from each cell
type from individual horses. Following cell loading, scaffolds
were divided in half and randomly assigned to a culture
medium and time point. There were four replicates for each
outcome assessment, which were performed in duplicate for
all horses.
Cell Harvest, Expansion and Preservation
Inclusion criteria for cell donors were designed to identify a
clinically relevant population with limited variability attrib-
utable to breed, age, gender or comorbidities. Inclusion
criteria were: 1) thoroughbred; 2) 7–10 years; 3) gelding;
4) normal physical exam. For bone marrow harvest, horses
were sedated with detomidine HCl (0.04 mg/kg intravenous-
ly (IV)), an area over the cranial sternebrae was aseptically
prepared, and surface tissues were desensitized with 2 %
lidocaine. Bone marrow aspirates were collected through
10G 3-in bone marrow biopsy needles into heparinized syrin-
ges (1,000 IU/10 mL aspirate). The aspirate was diluted 1:1
with stromal medium (Dulbecco’s modified Eagle’s medium
(DMEM)-Ham’s F12 (Hyclone, Logan, UT, USA), 1 %
antibiotic/antimycotic solution (MP Biomedical, Irvine, CA,
USA), 10 % fetal bovine serum (Hyclone)), layered over
Ficoll-Paque® PLUS (Stem Cell Technologies, Vancouver,
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Canada), and centrifuged at 1,400 r.p.m. (350 g) for 30 min at
4 °C. The cell layer was aspirated and centrifuged
(1,200 r.p.m. (260 g), 5 min, 4 °C). The cell pellet was then
resuspended in 10 mL of stromal medium. The total viable
nucleated cell number was determined based on trypan blue
exclusion.
Under the same sedation and following aseptic prepara-
tion, skin was desensitized over the gluteal musculature with
2 % lidocaine. A 10 cm horizontal skin incision was made
with a #10 scalpel blade, and subcutaneous adipose tissue
(15 mL) was sharply excised. Care was taken to avoid fascia
tissue during the harvest procedure. Skin was opposed with
#0 nylon skin sutures in a simple interrupted pattern.
Adipose tissue was minced and mixed with an equal volume
of phosphate buffered saline (PBS). The mixture was
allowed to separate into two phases, and the infranatant was
digested for 2 h at 37 °C in an equal volume of PBS with 1 %
bovine serum albumin (BSA) and 0.1 % type I collagenase
(Worthington Biochemical, Lakewood, NJ, USA). After ad-
dition of 5 mL 1 % BSA, the mixture was centrifuged
(1,200 r.p.m. (260 g), 5 min, 4 °C), and the resulting stromal
vascular fraction (SVF) pellet was resuspended in stromal
medium. Viable cell number was determined as above.
Cell isolates were cultured (37ºC, 5 % CO2) in stromal
medium. For purposes of this study, the initial cell isolate is
considered the stromal vascular fraction (SVF). The first cell
passage is considered P0. At 75 % confluence, SVF cells
were detached with 0.05 % trypsin and seeded at 5×103
cells/cm2. When the cells (P0) reached 75 % confluence,
they were detached as before and cell aliquots (P1, 1×106
cells/ml) in cryopreservation medium (80 % fetal bovine
serum (FBS), 10 % DMEM, 10 % dimethylsulfoxide) were
maintained in liquid nitrogen for a minimum of 30 days.
Immunophenotype–Flow Cytometry
Following thawing (1 min, 37 °C), P1 MSC aliquots from each
horse were cultured in stromal medium for 4 days. Cells were
passaged at 75 % confluence and seeded at 5×103 cells/cm2
(P2). When cells reached 75 % confluence, they were detached
with 0.05% trypsin and aliquots (P3, 5×103 cells/horse, n=4) of
each cell type were combined (2×105 cells total) in 200 ml PBS
and incubated with 5 μg of unlabeled CD29 (α-human, catalog
#610468, BD Biosciences, San Jose, CA, USA), unlabeled
CD44 (α-feline, equine reactivity, catalogue # CT-BOV2037,
Washington State University Monoclonal Antibody Center,
Pullman, WA) or CD105-PE (α-human, catalog #12-1057,
eBioscience, San Diego, CA, USA) antibodies for 30 min at
room temperature. For CD29 and CD44, indirect immunofluo-
rescence was performed by incubation with goat anti-mouse Ig-
FITC (Sigma Aldrich, Saint Louis, MO, USA) for 30 min at
room temperature. Following incubation, cells were washed
with PBS and fixed with 2 % paraformaldehyde. Surface
antigen expression was determined based on comparisons with
negative controls illustrated on 10,000 even histogram plots
using a fluorescence-activated cell sorting flow cytometer
(FACSCalibur, BD Biosciences) and software (CellQuest Pro,
BD Biosciences). The specificities of antibodies that were not
specifically designated as equine reactive were confirmed by
standard western blot band colocalization with human MSC
controls at the level provided by the manufacturer [26].
Collagen Scaffold
The scaffold material used in this study was composed of a
commercially available collagen sponge (AviteneTM
UltrafoamTM Collagen Sponge, Davol Inc., subsidiary of
C.R. Bard, Inc. Warwick, RI, USA). The purified bovine
corium collagen sponge is porous, pliable, water insoluble
and bioabsorbable. Sterile 8×12.5×0.3 cm sheets were cut
into 14×10×3 mm pieces under aseptic conditions.
Saturation of the scaffold material with medium resulted in
30 % shrinkage to give final dimensions of 10×7×2 mm.
Hydrated, individual scaffolds were loaded with cells within
perfusion bioreactors as described below.
Loading Efficiency
Following revitalization and culture expansion of P1 cell
aliquots as described above, cells (P3) were detached with
0.05 % trypsin [4, 5], rinsed with PBS, and resuspended in
stromal medium following cell quantification. Cells
suspended in stromal mediumwere loaded onto scaffolds with
a perfusion bioreactor system [27] (Fig. 1). Each system was
composed of two bioreactors connected to each other on their
lowermost ends and to a peristaltic pump (Ismatec 404b,
Glattbrugg, Switzerland) on their uppermost ends with
4.8 mm inner diameter flexible tubing (Tygon, Compagnie
de Saint-Gobain, Courbevoie, France). There were three way
stopcocks at the top of each bioreactor and 0.22 μm syringe
filters (Millipore, Billerica, MA, USA) between tubing at-
tached to the bioreactor and tubing attached to the pump.
One bioreactor in each system had a stopcock at its lowermost
end.
Fluid flow direction and rate were controlled by a com-
puter program (LabVIEW, v8.2, National Instruments
Corporation, Austin, TX, USA). Scaffolds were hydrated in
medium and then placed about 5 mm from the low end of
each bioreactor such that fluid flowed only along the short
axis. The hydrated scaffolds assumed the shape of the bio-
reactor chambers, and the relative position and orientation
was maintained by close approximation of the scaffold pe-
rimeter with the chamber walls. Some minimal vertical dis-
placement was possible during perfusion (~1–3 mm), but
orientation was maintained. Systems were primed with stro-
mal medium (5 ml) through the lowermost stopcock
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followed by addition of MSC suspensions (3 ml, 1×106
cells) through the stopcock on the top of each bioreactor.
Perfusion was performed for 2 h (37ºC, 5 % CO2) at a fluid
flow rate of 1.05 ml/min (0.97 mm/s). Flow rate was selected
based on preliminary tests to optimal cell loading for the
system, scaffold and cells [23, 28]. Flow direction was
reversed after medium reached the top of a bioreactor so that
scaffolds remained immersed.
Following loading, scaffolds were removed, medium col-
lected and the system rinsed with 4 ml of 0.05 % trypsin
(Hyclone). Medium and trypsin were centrifuged (350 g,
5 min), cells quantified by hemocytometer and the percent
loading efficiency calculated as 100(1−[(cells in medium +
cells in trypsin)/initial cell number]). After loading, scaffolds
were evaluated or maintained in culture medium according
to the study design.
Viable Cell Distribution–Confocal Laser Microscopy
Constructs were incubated in darkness for 30 min at room
temperature with a live/dead stain (LIVE/DEAD, Molecular
Probes, Eugene, OR, USA) such that live cells fluoresced
green while non-viable cells fluoresced red. A total of
20 consecutive photomicrographs (10×) of the entire scaf-
fold cross-section along the short axis were generated
every 100 μm (uppermost to lowermost surface) using a
spectral confocal laser scanning microscope digital imag-
ing system (Leica TCS SP2, Leica Microsystems, Buffalo
Grove, IL, USA). Images were generated from the upper-
most surface of the scaffold relative to the position in the
bioreactor to the lowermost surface. Graphics software
(ImagePro® Media Cybernetics, Bethesda, MF, USA)
boundary conditions were set according to the average
pixel number (red or green), corresponding to non-viable
and viable cells, respectively. Numbers of viable and non-
viable cells in each image were estimated based on the
number of green and red pixels. The percentage of viable
cells was calculated from n=20 images taken at the center
(n=10) and at the periphery (n=10). The spatial uniformi-
ty ratio was then calculated as % viable surface cells/%
viable center cells. This measure was included in the study
design to quantify viable cell distribution [29]. The spatial
uniformity was evaluated by comparison to completely
homogeneous distribution of viable cells across the periph-
eral and central regions (ratio of 1). Values >1 indicate a
larger percentage of viable cells near the scaffold surface,
and values of <1 indicate a larger percentage of viable
cells near the center of the scaffold.
Lineage Differentiation–Static Culture Conditions
Constructs in 24 well plates (CellStar, BioExpress, Kaysville,
UT, USA) were maintained for 7, 14 or 21 days in stromal or
differentiation medium with media changes every 3 days
(Table 1). For adipogenesis, constructs were initially cultured
for 6 days in induction medium followed by maintenance
medium.
Microstructure–Light Microscopy
Scaffolds were fixed in 4 % neutral buffered formalin, par-
affin embedded, sectioned (5 μm) and stained with Masson’s
trichrome. Samples cultured in osteogenic or chondrogenic
medium were additionally stained with von Kossa stain
(calcium) and alcian blue (proteoglycan), respectively.
Cell Number–DNA Quantity
Constructs stored in TRIReagent (Molecular Research
Center, Inc., Cincinatti, OH, USA) at −80 °C after culture
were thawed at room temperature (1 min), homogenized
(TissueLyser II, Qiagen, Valencia, CA, USA), and DNA
and total RNA were isolated by phenol-chloroform extrac-
tion [30]. Spectrophotometric (NanoDrop ND-1000,
Thermo Scientific, Wilmington, DE, USA) quantification
of DNA was performed. The DNA concentration was in
addition determined from the 260/280 nm optical density
ratio [31, 32]. The total cell number in each scaffold was
Fig. 1 Photograph of the bioreactor system and a collagen scaffold
within an individual bioreactor chamber viewed from the top (upper
inset) and side (lower inset). A bioreactor chamber within the system is
indicated within a small grey rectangle. The hydrated scaffolds as-
sumed the shape of the bioreactor chambers, and the relative position
and orientation was maintained by close approximation of the scaffold
perimeter with the chamber walls
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determined on standard curves of DNA quantity versus
numbers of ASC and BMSC [33].
Target Gene Expression–qRT-PCR (Quantitative Reverse
Transcription-Polymerase Chain Reaction) mRNA Levels
Following DNAase (Sigma) treatment, RNAyields were deter-
mined spectrophotometrically (Nano-drop® ND-1000,
Wilmington, DE, USA). RNAwas reverse-transcribed to com-
plimentary DNA using oligo(dT) primers (Sigma) andMoloney
murine leukemia virus reverse transcriptase (Sigma). Equine
primers were designed for MSC (homeobox protein Nanog
[Nanog], sex determining region Y-box 2 [Sox2]), as well as
adipogenic (peroxisome proliferator-activated receptor gamma
[PPARγ], leptin), osteogenic (COLI, alkaline phosphatase
[ALP]) and chondrogenic (collagen type II [COLII], sex deter-
mining region Y- box 9 [SOX9]) differentiation using
Primer3Plus (http://www.primer3plus.com/cgi-bin/dev/
primer3plus.cgi) (Table 2).
Target gene mRNA levels were quantified with qRT-PCR
using SYBR Green technology (Bio-Rad, Hercules, CA, USA)
and an ABI Prism 7900HT sequence detection system (Applied
Biosystems, Carlsbad, CA,USA). The threshold cycle (Ct) value
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
subtracted from that of each target gene to determine ΔCt.
Lower ΔCt values are consistent with higher mRNA levels
while lower mRNA levels have higher ΔCt values. In the case
of target gene mRNA signals that cross the threshold earlier than
Table 1 Induction media
Induction Reagent Concentration
Chondrogenesis High glucose DMEM-Ham’s F12 –
Fetal bovine serum 1 %
Antibiotic/antimycotic 1 %




Sodium pyruvate 100 μg/ml
1 % ITS + Premix 6.25 μg/ml insulin, 6.25 μg/ml
transferrin, 6.25 ng/ml selenious acid,
1.25 mg/ml bovine serum albumin, and
5.35 mg/ml linoleic acid
Osteogenesis DMEM-Ham’s F12 –




Sodium 2-phosphate ascorbate 50 μg/mL
Adipogenesis induction
(6 days of culture)
DMEM-Ham’s F12 –
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reference gene mRNA levels, the ΔCt value is negative. The
more negative theΔCt value, the higher the target gene mRNA
levels.
Ultrastructure–SEM
After culture, constructs were fixed in 2 % paraformaldehyde
and 1.25 % glutaraldehyde in 0.1 M sodium cacodylate buffer
[26]. Samples were dehydrated in a series of ethanol-distilled
water solutions, critical point dried (Polaron, Quorum
Technologies, ltd, New Haven, East Sussex, UK) and sputter
coated with gold and palladium. They were imaged with SEM
(Quanta 200, FEI Company, Hillsboro, OR, USA) at 15 kVP.
Statistical Analysis
Outcomes are reported as mean ± standard error of the
mean (SEM). Two replicates for each of the four horse
donors were available for each outcome. All response
variables were considered continuous and tested for
normality using the Shapiro-Wilk statistic. Differences
in loading efficiency between cell types were assessed
with paired Student’s t-tests within horse. Three- and
two-way ANOVA models were used to determine fixed
effects of cell type, culture time and induction medium
on cell viability and fixed effects of cell type and
culture time on mRNA expression levels, respectively.
The variation between individual horses was included as
the error term for analysis of fixed effects. Significant




In combined aliquots of P3 ASC and BMSC harvested from
all horses, 99 % of ASC and 90% of BMSC expressed CD29,
99 % of ASC and 99 % of BMSC expressed CD 44 and 87 %
of ASC and 64 % of BMSC expressed CD105 (Fig. 2).
Loading Efficiency
Loading efficiencies were not significantly different between
BMSC (74.6±14.4 %) and ASC (85.8±9.20 %).
Viable Cell Distribution–Confocal Laser Microscopy
Spatial uniformity ratio of viable cells was not affected by cell
source, medium type or culture period (Fig. 3, upper). In most
cases, the mean spatial uniformity ratio values approximated 1,
indicating comparable distribution among surface and center
scaffold regions. Immediately after loading, viable cells appeared
distinct from each other. Numerous small aggregates of viable
cells formed following a period of culture (Fig. 3, lower).
Table 2 Equine primer
sequences Gene Primer sequence NCBI reference sequence
accession number
Multipotentiality NANOG 5’-3’ CCCAGCTCTGTGTCCTCAAT XM_001498808
3’-5’ TTGCTAGTCTTCGGCCAGTT
SOX2 5’-3’ CAGCTCGCAGACCTACATGA XM_003363345
3’-5’ TGGAGTGGGAGGAAGAGGTA












Housekeeping GAPDH 5’-3’GTGAGCTTCCCATTCAGCTC NM_001163856
3’-5’ATCACTGCCACCCAGAAGAC
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Fig. 2 Representative immunophenotype of equine adult equine adipose–(ASC, upper) and bone marrow (BMSC, lower) derived multipotent
stromal cells loaded onto collagen type I scaffolds. Black curves represent stained cells and green curves autofluorescence
Fig. 3 Spatial uniformity ratio (mean ± SEM) of viable cells in
adipose–(ASC, upper left) and bone marrow (BMSC, upper right) de-
rived multipotent stromal cell–collagen type I (COLI) constructs after 0,
7, 14 or 21 days of culture in adipogenic, chondrogenic, osteogenic or
stromal medium. The spatial uniformity ratio of viable cells was not
affected by cell source, medium type or culture period. Confocal laser
scanning microscopy photomicrographs representative of both ASC-
COLI and BMSC-COLI constructs immediately after cell loading (lower
left) and after 21 days of culture in stromal medium (lower right) dem-
onstrate cell distribution in the scaffolds. Immediately after loading,
viable cells appeared distinct from each other (lower left). Numerous
small aggregates of viable cells formed following a period of culture
(lower right). (2.5×, calcein/ethidium bromide)
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Microstructure–Light Microscopy
The MSCs on COLI scaffolds cultured in induction medium
assumed cell phenotypes consistent with the lineage speci-
ficity of the culture medium, and cells were enmeshed in
ECM as early as after 7 days of culture. Differences over
time were primarily related to cell organization within in-
creasing amounts of ECM. Cells on constructs cultured in
adipogenic medium were vacuolated and had an ellipsoid
shape (Fig. 4a, b). Intracellular vacuoles were assumed to be
the result of adipogenic lipid deposition [34]. Cells in small,
loose clusters were present within amorphous ECM. In
chondrogenic medium, elongated cells with indistinct nuclei,
some within early lacunae, were tightly clustered in a col-
lagenous matrix (Fig. 4c, d) [35–37]. Constructs in osteo-
genic medium had loose cell clusters of round cells with
small, dark nuclei, some within developing lacunae, and
spindle shaped cells within collagenous matrix (Fig. 4e, f).
Both ASC and BMSC constructs cultured in stromal medium
had minimal ECM and cell morphology was consistent with
the tissue harvest source (Fig. 4g, h). Based on subjective
assessment, the amount of ECM that stained with alcian blue
increased in all scaffolds with time of culture in
chondrogenic medium (Fig. 5). Von Kossa staining of calci-
um deposits was evident as early as after 7 days of culture in
osteogenic medium (Fig. 5).
Cell Number–DNA Quantity
Culture time and medium type affected ASC numbers while
only medium type affected BMSC numbers on constructs, and
there were no differences attributable to cell source. There
were significantly more cells in BMSC constructs cultured in
chondrogenic medium than in adipogenic (P<0.05) or stromal
(P<0.01) medium after 21 days of culture (Fig. 6). The ASC
constructs in stromal medium had significantly higher cell
numbers than those in induction medium after 21 days
(P<0.001), and ASC constructs cultured in stromal medium
had significantly more cells after 21 versus 7 (P<0.001) and 14
(P<0.01) days of culture.
Target Gene Expression–qRT-PCR mRNA Levels
All of the following results were statistically significant.
Gene expression after 14 and 21 days of culture are com-
pared to 7 days of culture. Levels of PPARγ were higher in
ASC- versus BMSC constructs after 14 days of culture in
adipogenic medium (P<0.001) and LEP was higher after 7
(P<0.001) and 14 (P<0.001) days of culture (Fig. 7a, b).
The PPARγ mRNA levels decreased in both constructs after
14 (ASC P<0.01; BMSC P<0.001) and 21 (ASC P<0.01;
BMSC P<0.01) days of culture and LEPmRNA increased in
BMSC constructs after 14 days (P<0.001) and in both con-
structs after 21 days of culture (ASC P<0.001; BMSC
P<0.001). In chondrogenic medium, construct COLII and
SOX9 mRNA levels were higher in BMSC versus ASC
constructs at all time points (P<0.001) with the exception
of COLII after 21 days (Fig. 7c, d). Levels of COLII in-
creased in BMSC- and ASC constructs after 14 (ASC
Fig. 4 Photomicrographs of adult equine bone marrow- (BMSC; a, c, e,
g) and adipose (ASC; b, d, f, h) derived multipotent stromal cell–collagen
type I (COLI) constructs after 21 days of culture in adipogenic (a, b),
chondrogenic (c, d), osteogenic (e, f) or stromal medium (g, h). Cells (a,
b; black arrows) on constructs cultured in adipogenic medium were
vacuolated and had an ellipsoid shape. Cells (a, b; black arrows) in small,
loose clusters were present within amorphous ECM (a, b; red arrows). In
chondrogenic medium, elongated cells with indistinct nuclei (c, d; black
arrows), some within early lacunae (c, d; asterisks), were tightly clustered
in a collagenous matrix (c, d; red arrows). Constructs in osteogenic
medium (e, f) had loose cell clusters of round cells with small, dark nuclei
(f, black arrow), some within developing lacunae (e; asterisk), and
spindle shaped cells (e, black arrow) within collagenous matrix (e, f;
red arrows). Both ASC-COLI and BMSC-COLI constructs cultured in
stromal medium had minimal extra-cellular matrix (g, h; red arrows) and
cell morphology (g, h; black arrows) was consistent with the tissue
harvest source, bone marrow (g) or adipose (h). Scaffold remnants were
evident in all images (a–h; yellow arrows). Cells (black arrows), new
extracellular matrix (red arrows), scaffold remnants (yellow arrows) and
lacunae in various stages of development (asterisks) are shown. (100×,
Masson’s trichrome stain, scale bar = 10 μm)
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P<0.001; BSMC P<0.001) and 21 (ASC P<0.001; BSMC
P<0.001) days of culture. Similarly, levels of SOX 9 also
increased in BMSC- and ASC constructs after 14 (ASC
P<0.001; BSMC P<0.001) and 21 (ASC P<0.01; BSMC
P<0.001) days of culture. For constructs cultured in osteo-
genic medium, levels of COLI mRNA were higher in
BMSC- compared to ASC constructs at all time points (7-
days P<0.05; 14 days P<0.001; 21 days P<0.001), and
levels increased in BMSC constructs after 14 (P<0.01) and
21 (P<0.001) days of culture (Fig. 7e). BMSC construct
ALP mRNA levels were higher than ASC after 7 days of
culture (p<0.001) (Fig. 7f). Levels were higher and lower in
Fig. 5 Light photomicrographs of adult equine adipose (ASC) and
bone marrow- (BMSC) derived multipotent stromal cell–collagen type
I constructs cultured for 7, 14 or 21 days in chondrogenic (left two
columns, alcian blue stain, 63×) or osteogenic (right two columns, von
Kossa stain, 63×) medium. In constructs cultured in chondrogenic
medium, cells (left two columns; black arrows) and new extra-cellular
matrix (left two columns; red arrows) are evident. In those cultured in
osteogenic medium, cells (right two columns; black arrows) and von
Kossa staining of calcium deposits (right two columns; blue arrows) are
visible. Based on subjective assessment, the amount of extra-cellular
matrix that stained with alcian blue increased in all scaffolds with time
of culture in chondrogenic medium. Von Kossa staining of calcium
deposits was evident as early as after 7 days of culture in osteogenic
medium
Fig. 6 Number (mean ± standard error of the mean) of cells adult
equine adipose- (ASC; left) and bone marrow- (BMSC; right) derived
multipotent stromal cell–collagen type I constructs after 7, 14 or 21 days
of culture in adipogenic, chondrogenic, osteogenic or stromal medium.
* on columns = Significant differences from day 7 within culture
medium cohorts. * above columns = Significant differences between
culture media within time points (P<0.05)
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ASC constructs after 14 (P<0.01) and 21 (P<0.001) days of
culture, respectively. Levels decreased in BMSC constructs
after 14 (P<0.001) and 21 (P<0.001) days of culture. There
were no significant differences in Nanog or SOX2 mRNA
levels between cell types within time points or within cell
types between time points in constructs cultured in stromal
medium (Fig. 7g, h).
Ultrastructure–SEM
Ultrastructure showed lineage-specific cell morphology and
ECM (Fig. 8). Constructs in adipogenic medium had round to
ellipsoid cells in amorphous matrix. Scaffold constructs in
chondrogenic medium had spherical cells embedded in dense,
highly organized ECM. Those in osteogenic medium had
Fig. 7 Delta CT (ΔCT) (mean
+/− standard error of the mean)
for target gene mRNA levels in
adult equine bone marrow-
(BMSC) and adipose (ASC)
derived multipotent stromal cell–
collagen type I (COLI)
constructs after 7, 14, or 21 days
of culture in adipogenic (a, b),
chondrogenic (c, d), osteogenic
(e, f) or stromal (g, h) medium. *
on columns = significant
differences between cell types
within time points. # above
columns = significant differences
from day 7 within cell type
(P<0.05). Lower ΔCt values are
consistent with higher mRNA
levels while lower mRNA levels
have higher ΔCt values. In the
case of target gene mRNA
signals that cross the threshold
earlier than reference gene
mRNA levels, the ΔCt value is
negative. The more negative the
ΔCt value, the higher the target
gene mRNA levels
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flattened, polygonal and spindle-shaped cells adhered to colla-
gen fibers and surrounded by mineral deposits [38]. Constructs
in stromal medium were characterized by abundant, poorly
organized collagen fibrils.
Discussion
Comparable mesenchymal trilineage differentiation and ECM
production was successfully achieved with equine ASC and
BMSC seeded in COLI scaffolds with lineage specific culture
media in this study. Cells had similar loading efficiency, via-
bility, and spatial distribution following identical perfusion
bioreactor loading and static culture, supporting the first hy-
pothesis. Though ASC tended to exhibit earlier and greater
upregulation of adipogenic target genes, and the same was true
for BMSC and osteogenic target genes, some differences in
mRNA levels between cell types declined with culture time and
micro- and ultrastructure was not greatly different between
them. Similarly, though BMSC had earlier and higher
upregulation of chondrogenic target genes, proteoglycan stain-
ing and micro- and ultrastructures were comparable between
ASC and BMSC. Contradictory to the second hypothesis,
these results confirm that the capability of cryopreserved
MSC for adipogenic, osteogenic and chondrogenic differenti-
ation and ECM production did not significantly depend on
tissue source.
Perfusion bioreactor seeding of COLI scaffolds used in
this study was a reliable, repeatable mechanism to load and
distribute adult equine ASC and BMSC into COLI scaffolds
at a cell density (~5×106 cells/cm3) within the range of those
reported for mesenchymal tissue generation [14, 15, 39].
Cell seeding by repeated perfusion through scaffold en-
hances cell number and distribution, which in turn promote
uniform tissue generation and reduce time required for the
generation process itself [21, 23]. Optimal fluid flow rate is
uniquely determined by scaffold microstructure; velocities
that are too high interfere with cell adhesion and those that
are too low do not move cells through the system or distrib-
ute them throughout the scaffold [23, 27, 40]. As described
in “Materials and Methods”, the flow rate was selected based
on preliminary work. While further optimization may be
possible, the perfusion rate used in this study resulted in
loading efficiencies that are consistent with comparable stud-
ies [21, 23, 27].
The numbers of cells on the scaffolds based on DNA
content remained relatively stable with the exception of a
large increase in ASC constructs cultured in stromal medium
and gradual increase in BMSC constructs in chondrogenic
medium. These findings may have been due to continued
undifferentiated cell proliferation [41] and cell proliferation
accompanying chondrogenic differentiation [42, 43], respec-
tively. The otherwise stable cell numbers support the ob-
served cell differentiation [44].
Culture of three-dimensional MSC-scaffold constructs in
perfusion bioreactors likely provides more favorable and phys-
iologically comparable conditions than the static culture condi-
tions used in this study [23, 27, 40]. The continuous flow
through perfusion bioreactor systems allows dynamic nutrient
supply, gas exchange and waste removal. Additionally, fluid
perfusion helps to maintain similar local environments in sur-
face and center scaffold regions. This point is especially relevant
Fig. 8 Scanning electron photomicrographs of adult equine bone mar-
row- (BMSC; a–c) and adipose (ASC; d–f) derived multipotent stromal
cell–collagen type I (COLI) constructs cultured in adipogenic (a, d),
chondrogenic (b, e) or osteogenic (c, f) medium for 21 days. A scaffold
without cells (Scaffold) and with ASC in stromal medium (Stromal) are
shown for comparison. Constructs in adipogenic medium had round (a;
black arrow) to ellipsoid (d, black arrow) cells in amorphous matrix (a;
M) containing lipid droplets (d; white arrows) and collagen fibrils (d;
gray arrow head). Scaffold collagen fibers were also visible (a; black
arrow head). Scaffold constructs in chondrogenic medium had dense,
highly organized extracellular matrix (b, e; M) with abundant collagen
fibrils (b, e; gray arrow heads). Those in osteogenic medium had flat-
tened, polygonal cells (c; black arrow) adhered to collagen fibers (c, f;
black arrow heads) with mineral deposits (c, f; white arrow heads) and
collagen fibrils (c, f; gray arrow heads) in the surrounding matrix.
Constructs in stromal medium were characterized by abundant, poorly
organized collagen fibrils (Stromal; gray arrow head) surrounding colla-
gen fibers (Stromal; black arrow head). (Scale bars = 10 μm)
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for larger engineered tissue constructs that have smaller surface
area to volume ratios. It was not possible to maintain the large
number of constructs required for this study in available bio-
reactors for the extended culture periods within the study period.
Despite this potential limitation, the constructs had ECM for-
mation and viable cells throughout, indicating that static culture
with regular media changes was sufficient to support cell via-
bility and differentiation. This finding has been previously
reported for MSC on comparably sized COLI scaffolds [14].
However, dynamic perfusion may provide a physiochemical
environment that is more inductive to tissue formation with
optimum nutrient delivery, gas exchange and waste removal in
larger constructs [40].
The ability of equine ASC and BMSC to differentiate into
adipogenic, chondrogenic and osteogenic lineages is
established [4, 5, 8]. Though there is no clear agreement,
MSC appear to have a propensity to assume their lineage of
origin under standard induction conditions, potentially due
to epigenetic programming [45–48]. Tissue specific target
gene upregulation by ASC- and BMSC-COLI constructs in
this investigation generally support this concept, though the
micro- and ultrastructure did not appear different between
ASC and BMSC constructs. The mRNA levels tended to
increase with induction in all scaffolds with the exception of
PPARγ and ALP, which decreased as expected with cell
maturation [35, 48, 49]. Epigenetic processes may support
a more rapid response of adult MSCs to induction media of
their tissue of origin [50]. However, it is conceivable that
effects are less profound with respect to ECM production
since genetic upregulation based on mRNA levels does not
necessarily directly correlate with protein formation central to
tissue engineering [42, 51]. These results support comparable
mesenchymal trilineage differentiation and ECM forming ca-
pabilities of equine BMSC and ASC on COLI scaffolds.
Longer in vitro culture periods and controlled in vivo com-
parisons may help reveal differences in quality and function of
mature tissues from different cell sources.
The donor population in this study was selected to elim-
inate variability from age, gender or breed. The MSC phe-
notype was confirmed by expression of cell surface antigens
[52–54]. Relatively low CD105 expression relative to CD29
and CD44 by MSCs has been previously reported in several
species, including equine [54]. Taken together, the results
support an MSC phenotype from both tissue sources used in
this investigation.
Scaffolds composed of COLI were used in this investiga-
tion for comparison between MSC to produce tissue specific
matrix directed only by induction media on a ubiquitous
component of mesenchymal ECM [12, 13]. Scaffolds are
often customized for specific tissue generation by addition
of tissue specific growth factors or ECM proteins, among
other components [55]. As indicated above, we sought to
establish the potential of ASC and BMSC to differentiate and
produce mesenchymal ECM without scaffold alterations. It
is possible that scaffolds tailored to cell type and tissue target
may enhance the mesenchymal ECM forming potential seen
in this investigation.
Xenogeneic collagen implants have the potential to be
antigenic and immunogenic. There is a report of human hu-
moral responses to a commercially available bovine COLI
implant, ZYDERM® [56]. The physician package insert for
the product indicates that fewer than 1 % of recipients have
self-limiting, local inflammatory reactions that may persist
throughout the life of the implant. According to the insert,
the reactions do not affect the long-term success of the colla-
gen implant corrections. An in vitro study showed that porcine
and human COLI elicit proliferation of human immune cell
subpopulations in co-stimulation with anti-CD3 antibodywith
accompanying release of cytokines interferon gamma and
tumor necrosis factor alpha [57]. A more recent in vitro study
showed that xenogeneic COLI did not trigger maturation of
human dendritic cells and had no effect on B or T cell prolif-
eration or cytokine response [58]. Further, a previous study
showed that the local inflammatory reaction to scaffolds com-
posed of β-tricalcium phosphate and bovine COLI was re-
duced by implantation with syngeneic or allogeneic ASCs in a
rat spinal fusion model [59]. Finally, a recent report indicates
that ovine amnionic epithelial cell xenografts in naturally
occurring equine superficial digital flexor tendon injuries pro-
duced ovine COLI without apparent rejection [60]. Given
potential immunogenicity of COLI xenografts, preclinical
and clinical outcome assessments should include evaluations
of local and systemic responses with the understanding that
there is potential for immune stimulation.
There are a number of approaches to MSC-scaffold tissue
formation, two of which include implantation of constructs
after a short in vitro incubation for cell attachment or orthotopic
placement after one to several weeks of in vitro culture in
inductionmedium forMSC differentiation and ECM formation
[61]. A potential limitation of the former is reliance on the
recipient microenvironment to direct cell differentiation and
ECM formation [62]. Microenvironmental changes from local
or systemic pathology may disrupt normal MSC function and
differentiation [63]. In contrast, constructs that contain differ-
entiated cells and tissue-specific ECM from pre-implantation
culture in induction medium may serve as a source of growth
factors to recruit and direct native progenitor cells as well as to
provide an ECM matrix for tissue conduction and engraftment
[64]. It is imperative to fully characterize in vitroMSC behavior
in scaffolds to identify the best combinations and preimplanta-
tion culture conditions prior to in vivo implantation.
The comparable abilities of cryopreserved adult equine
ASC and BMSC for adipogenic, osteogenic and chondrogenic
differentiation and ECM production on COLI scaffolds
in vitro following perfusion bioreactor loading and culture in
this study is vital to efforts toward translation of MSC tissue
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engineering to equine patients. In vivo validation of the find-
ings through preclinical models prior to controlled clinical
trials will continue the momentum toward a goal of custom-
ized, viable tissue implants to augment fracture, wound and
intra-articular therapies.
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